Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008.
about
Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinolGout Classification Criteria: Update and ImplicationsThe effect of angiotensin II receptor blockers on hyperuricemiaGout and Risk of Myocardial Infarction: A Systematic Review and Meta-Analysis of Cohort StudiesFilipino gout: a reviewThe management of goutReview: Gout: A Roadmap to Approaches for Improving Global OutcomesRegulation of Nlrp3 inflammasome by dietary metabolitesA review of uric acid, crystal deposition disease, and gout.Gout in immigrant groups: a cohort study in SwedenPrevention of comorbidity and acute attack of gout by uric acid lowering therapyThe Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study.Clinical and health care use characteristics of patients newly starting allopurinol, febuxostat, and colchicine for the treatment of gout.Comorbidities in patients with crystal diseases and hyperuricemia.Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational studyReduced glomerular function and prevalence of gout: NHANES 2009-10Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without goutRisk factors for incident hyperuricemia during mid-adulthood in African American and white men and women enrolled in the ARIC cohort studyGout, urate-lowering therapy, and uric acid levels among adults in the United StatesIndependent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study.Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies.Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study.Bidirectional Association between Self-Reported Hypertension and Gout: The Singapore Chinese Health Study.Intestinal Microbiota Distinguish Gout Patients from Healthy HumansCharacteristics of the first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia: a cross-sectional observational studyGout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study.Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes.Comorbidities in patients with gout prior to and following diagnosis: case-control study.Sleep Apnea and the Risk of Incident Gout: A Population-Based, Body Mass Index-Matched Cohort Study.Bidirectional Association between Diabetes and Gout: the Singapore Chinese Health Study.Tophaceous Gout in an Anorectic Patient Visualized by Dual Energy Computed Tomography (DECT).Association of kidney disease with prevalent gout in the United States in 1988-1994 and 2007-2010.Poorly controlled gout: who is doing poorly?Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective AnalysisGout in Older Adults: The Atherosclerosis Risk in Communities Study.Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims.Genetic analysis of the ELOVL6 gene polymorphism associated with type 2 diabetes mellitus.Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers.Occurrence of gout in rheumatoid arthritis: it does happen! A population-based study.Low-dose aspirin use and recurrent gout attacks.
P2860
Q24658504-4CFE440D-1104-47DA-83A9-F29267659400Q26747158-BAB0DAC2-A0EF-4521-8784-C70B5A96F29BQ26777082-1A3B48AC-E1C7-4A95-8ADA-80F3175B8B3EQ26800933-0D997754-354D-40D6-AE7D-6D863D3C7716Q27027299-BF065C78-C058-44D8-8E66-5FB64857B87AQ28069759-60D156EC-514A-485F-BFA1-A34F7EFE6CA9Q28076018-16E86AF9-B418-474A-98FD-2EBEA59078BFQ28078340-29AE83D1-E393-4502-BD89-9CB18DBF3E92Q30619265-8961F438-FDBD-4067-B2BF-148D335ED1B6Q33592015-221F86C9-C318-432C-A470-9D0D6FDD0DE1Q33627488-056501C4-5427-4732-B8CD-0142FE1B4D95Q33652892-FDA50640-E808-47F3-BECC-393EE49C33A2Q33896768-862D4BD2-695A-4DD9-A882-EBE2A6C3AB74Q34157725-071640FD-843F-415E-BE83-855608C7762CQ34251600-42C3290C-60EA-48AA-BCB1-8152229A2BFEQ34499903-1314934D-6B7A-4478-9F00-9DA7595FC2B6Q34737229-F63A8B8D-8EF9-48C6-9438-4ED4D7482A6CQ35065173-A5EBBF5C-9A1E-4627-BFF0-68554CD6F87FQ35186048-2049CD7A-B1FF-4F57-91F4-43B2CE9362F3Q35306091-706B2362-2294-4A16-A400-D60550259EC7Q35503271-CC1D4E25-6F33-4CFC-8195-E63CB4A162BFQ35642254-9C21E007-2AD0-4E93-915C-C48AFFAF483FQ35824608-10BC9A4C-5D2B-4D88-9F70-E73CD45199E8Q35916817-2847D725-5FC9-4B7E-9B66-F2D36E27947AQ35964755-ED866250-6480-4EE4-84A7-7F2660F22C14Q36029745-20720B69-44EF-4E2E-BF4E-288784E97337Q36306524-4CD6844F-23A9-4462-BA53-B30968E5B305Q36475590-FE5470F0-99E7-4F0A-A855-851A1CAB49E0Q36766969-FE0BA0B6-4C0F-4599-B45D-87FD75EE0C95Q36886192-D8EDDD3A-0BF5-4005-9D66-03DD6A6095A8Q37103286-0CFE4281-7DBD-47A8-9D60-BAC0AC96A17DQ37125717-771CE3AD-6482-4D8A-9622-688852710DDDQ37195376-99D51D41-3DC2-42C8-9C7F-5AA99FA7F2EEQ37208467-DAB625CA-61A4-4A32-A1E0-696E7EE58DA4Q37238292-EADD6139-1AB4-4796-B8A9-A922CAB5CF6AQ37308677-DFF5EB9A-38B9-4651-9EA5-066B8883F058Q37383826-6EA76017-9E69-4DAE-8DC1-6733CC2BD591Q37397859-5CC84EC0-F250-46EA-9F6D-B84D870ABE84Q37477450-BC331618-991C-4B7E-AEB7-D811B4EADD17Q37517681-EF75AD08-5A20-42D5-A09B-DDBC148EA83F
P2860
Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008.
@en
Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008.
@nl
type
label
Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008.
@en
Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008.
@nl
prefLabel
Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008.
@en
Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008.
@nl
P2093
P1476
Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008.
@en
P2093
Bhavik J Pandya
Hyon K Choi
Yanyan Zhu
P304
679-687.e1
P356
10.1016/J.AMJMED.2011.09.033
P407
P577
2012-05-23T00:00:00Z